Presence of nucleotide substitutions in transcriptional regulatory elements such as the erythroid cell‐specific enhancer‐like element and theABOpromoter in individuals with phenotypes A3and B3, respectively

Authors:

Abstract
Background and objectives: An erythroid cell‐specific regulatory element, referred to as the +5.8‐kb site, has been identified in the first intron of the humanABOblood group gene. Subsequent studies have revealed involvement of deletion or mutation at the site in phenotypes Am, BmandABm. We investigated the molecular mechanisms involved in the A3and B3phenotypes.Materials and methods: GenomicDNAs were prepared from peripheral blood of seven A3individuals and twelve B3or AB3individuals, and the nucleotide sequences were investigated usingPCRand sequencing. Promoter assays were performed with K562 cells.Results: Two single point‐mutations at +5893 or +5909 in the site on theA‐allele were found in A3individuals, while promoter assays revealed decreased activity at the site as a result of each substitution. In two B3individuals, a single point‐mutation at −77 in theABOpromoter on theB‐allele was found, and the substitution was demonstrated to reduce the promoter activity.Conclusion: Nucleotide substitutions in the transcriptional regulatory elements such as the +5.8‐kb site and theABOpromoter appear to decrease transcription from theA‐andB‐alleles, resulting in reduction in A‐ and B‐antigen expression in A3and B3, respectively.